Ticker: ACHV

Company Overview: Achieve Life Sciences, Inc. (NASDAQ: ACHV) is a late-stage clinical specialty pharmaceutical company dedicated to addressing nicotine dependence through its sole product candidate, cytisinicline. Located in Bothell, WA, and Vancouver, Canada, the company is primarily focused on ...

Company Overview Achieve Life Sciences, Inc. (NASDAQ: ACHV) is focused on the development and commercialization of cytisinicline for treating nicotine dependence. As of March 31, 2025, the company holds a significant accumulated deficit and continues to require substantial capital for ongoing ope...